Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT Soho Global Health Tbk
SOHO
Sector: Healthcare
Industry: Pharmaceuticals
Sub Sector: Pharmaceuticals & Health Care Research
Sub Industry: Pharmaceuticals
Live quote
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
59
ROE
30,39%
ROA
13,33%
Book Value
193
Net Income
372,92 M
Total Sales
5,36 T
Total Assets
5,59 T
DER
1.28x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
0,33%
UOB KAY HIAN PTE LTD 🔗
40,03%
Securities Company · Asing
MEDISIA INVESTMENT HOLDINGS PTE. LTD. 🔗
22,47%
Private Equity · Asing
TIBERIAS 96 PTY LTD 🔗
10,00%
Investment Advisors · Asing
FRABURG PTY LIMITED 🔗
9,24%
Firm · Asing
TAN GIOK NIO 🔗
9,01%
Individual · Lokal
PRYSSELIUS LIMITED 🔗
4,92%
Mutual Funds · Asing
SUNRISE COMPANY LIMITED 🔗
4,00%
Corporate · Asing
Tentang Perusahaan
PT Soho Global Health Tbk (the Company), was established in Jakarta based on Notarial Deed No. 116 of Elisa Pondaag, S.H., dated August 27, 1956 under the name of PT Parit Padang. The Company started its commercial activitiesin 1956.
Produk & Lini Bisnis
The scope of Company activities comprises of holding and other management consulting activities. The Company conducts business in the field manufacturing and distribution of products in the pharmaceutical and health sectors through Subsidiaries
Dewan Direksi
EY
Ery Yunasri, SH,LL.M
President Director
RP
Rogelio Paulino Jr Castillo Lao
Director
Dewan Komisaris
EL
Eng Liang Tan
President Commissioner
HS
Harry Salam
Independent Commissioner
AN
Andy Nugroho Purwohardono
Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
PT Soho Industri Pharmasi
Pharmaceutical industry
 Jakarta 99.64%
PT Parit Padang Global
Pharmaceutical distributor
 Jakarta 99.99%
PT Universal Health Network
Pharmaceutical multi-level marketing
 Jakarta 99.98%
PT Soho Global Medika
Medical devices distributor
 Jakarta 99.80%
Trend Keuangan (5 periode terakhir) — hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
10,8M 8,1M 5,4M 2,7M 0 Sales 2025Q2: Rp 5.168.993.000 Net Income 2025Q2: Rp 290.360.000 2025Q2 Sales 2025Q3: Rp 7.924.506.000 Net Income 2025Q3: Rp 440.093.000 2025Q3 Sales 2025Q4: Rp 10.779.187.000 Net Income 2025Q4: Rp 600.321.000 2025Q4 Sales 2026Q1: Rp 2.635.637.000 Net Income 2026Q1: Rp 189.858.000 2026Q1 Sales 2026Q2: Rp 5.362.418.000 Net Income 2026Q2: Rp 372.922.000 2026Q2
2025 Q2
EPS 46
ROE 21,47%
2025 Q3
EPS 46
ROE 20,61%
2025 Q4
EPS 47
ROE 23,24%
2026 Q1
EPS 60
ROE 27,39%
2026 Q2
EPS 59
ROE 30,39%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q2 5,36 T 372,92 M 5,59 T 2,45 T 59 30,39% 1.28x
2026 Q1 2,64 T 189,86 M 5,80 T 2,77 T 60 27,39% 1.09x
2025 Q4 10,78 T 600,32 M 6,16 T 2,58 T 47 23,24% 1.38x
2025 Q3 7,92 T 440,09 M 6,01 T 2,85 T 46 20,61% 1.11x
2025 Q2 5,17 T 290,36 M 5,48 T 2,70 T 46 21,47% 1.03x
Trend Harga Penutupan & Book Value — hover titik untuk detail
Close Price Book Value
2,2K 1,7K 1,1K 622 103 Book Value 2025Q2: Rp 213 Close 2025Q2: Rp 680 2025Q2 Book Value 2025Q3: Rp 224 Close 2025Q3: Rp 785 2025Q3 Book Value 2025Q4: Rp 204 Close 2025Q4: Rp 1.370 2025Q4 Book Value 2026Q1: Rp 218 Close 2026Q1: Rp 2.000 2026Q1 Book Value 2026Q2: Rp 193 Close 2026Q2: Rp 1.060 2026Q2
2025 Q2
Close 680
BV 213
ROA 10,60%
2025 Q3
Close 785
BV 224
ROA 9,77%
2025 Q4
Close 1.370
BV 204
ROA 9,75%
2026 Q1
Close 2.000
BV 218
ROA 13,10%
2026 Q2
Close 1.060
BV 193
ROA 13,33%
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 2 1.060 193 13,33%
2026 1 2.000 218 13,10%
2025 4 1.370 204 9,75%
2025 3 785 224 9,77%
2025 2 680 213 10,60%
Data diperbarui pada: 2026-05-12 11:59:21